China health care companies received a significant reprieve in terms of geopolitical risks when the US Senate declined to ...

US investors and regulators have previously questioned the quality of clinical trial data gathered in China. Liang said the US Food and Drug Administration (FDA) has rejected drugs developed in the ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

What if China decided to sever American access to the drug ingredients your sick kid depends on? But America’s losing position in the biotechnology race with China has broader implications than just ...

The Chinese health care technology sector is in the midst of a transformative phase, fueled by breakthroughs in artificial ...

VCG. China plans to expand its institutional opening-up trial program at the nation's pilot free trade zones (FTZ), which is ai ...

The number of people prosecuted for spying for Beijing has risen sharply, with retired and serving members of Taiwan’s ...

CSPC Pharmaceutical Group Ltd. has obtained clearance from China’s National Medical Products Administration (NMPA) to conduct clinical trials with JMT-108 for advanced malignant tumors.

The assistance of an automatic quality control system improves adenoma detection rates among colonoscopists classified as ...